Prediction: New Reason Lilly Stock Could Still Rise
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
If you want minimal turnover, this guide highlights index funds with the least turnover and how to assess them for your portfolio.
27,312 articlesEli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Two clean-energy names. One clear question: which has the better odds of delivering big returns for investors over th...
Hims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
NVIDIA gains from a limited export-license shift that allows select Chinese firms to buy its top AI accelerators, but...
SpaceX's record IPO ignited a heated spacex wall street debating about AI spending and market risk. This piece breaks...
Meta Platforms expands its lead in scalable ads and AI infrastructure, widening the gap to Palantir, whose high multi...
A Murphy USA senior executive recently sold shares in an open-market move valued at roughly $344,000. This article br...
Looking for steady income in a volatile market? This guide highlights three high-yield energy stocks march investors ...
A practical, investor-friendly look at Gambling.com Group's Q1 2026 earnings. This deep dive breaks down revenue driv...
JetBlue sparked attention by boosting its Q2 unit-revenue outlook, lifting airline sentiment and offering clues for t...
When a chief executive sells stock, investors ask if the move is a red flag or a routine tax-related step. This piece...
Kaspi.kz faces a pivotal year as it expands its super app, grows its loan book, and navigates regional headwinds. Thi...